newsfilter
← Latest News
GlobeNewswire·

PLx Pharma Inc. Reports First Quarter 2022 Results and Provides Business Update

BUILDING A SOLID BASE OF VAZALORE® USERS Total Net Sales of $2.1 Million in the First Quarter of 2022, an Increase of Approximately 31% from Fourth Quarter of 2021 GAAP Net Loss of ($0.39) Per Diluted Share in the First Quarter 2022; Adjusted Non-G